Total | Male | Female | P | |
---|---|---|---|---|
n = 1205 | n = 531 (44.07%) | n = 674 (55.93%) | ||
Age (yr)* | 46.31 ± 15.14 | 45.49 ± 15.82 | 46.95 ± 14.56 | 0.100*** |
Se (μg/L)** | 52.63 (40.40-67.0) | 51.63 (39.41-66.23) | 53.14 (40.94-67.9) | 0.191*** |
TV (mL)** | 9.93 (7.71-12.57) | 10.83 (8.86-13.50) | 9.10 (7.26-11.57) | 0.001‡ |
Nodularity N (%) | 224 (18.6) | 75 (14.1) | 149 (22.1) | 0.001‡ |
Goiter N (%) | 106 (8.8) | 31 (5.8) | 75 (11.1) | 0.001‡ |
TPOAb (+) n (%) | 145 (12.0) | 40 (7.5) | 105 (15.6) | 0.001‡ |
TgAb (+) n (%) | 134 (11.1) | 28 (5.3) | 106 (15.7) | 0.001‡ |
Antibody (+) n (%) | 201 (16.7) | 49 (9.2) | 152 (22.6) | 0.001‡ |
TSH (mU/L) | 2.66 (1.81-3.66) | 2.45 (1.73-3.54) | 2.92 (1.9-4.13) | 0.001‡‡ |
BMI (kg/m2) | 22.90 ± 3.24 | 23.25 ± 3.03 | 22.62 ± 3.37 | 0.001*** |